Works matching DE "HEPATITIS C vaccines"
Results: 136
Vaccinating against Cancer.
- Published in:
- Innovation, 2007, v. 7, n. 3, p. 60
- By:
- Publication type:
- Article
Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2.
- Published in:
- Nature, 2014, v. 509, n. 7500, p. 381, doi. 10.1038/nature13117
- By:
- Publication type:
- Article
Completion of the entire hepatitis C virus life cycle in genetically humanized mice.
- Published in:
- Nature, 2013, v. 501, n. 7466, p. 237, doi. 10.1038/nature12427
- By:
- Publication type:
- Article
Chimp research under scrutiny.
- Published in:
- Nature, 2011, v. 480, n. 7378, p. 424, doi. 10.1038/480424a
- By:
- Publication type:
- Article
Recent Developments in Vaccines for Viral Diseases.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 198, doi. 10.3390/vaccines11020198
- By:
- Publication type:
- Article
HCV Core/NS3 Protein Immunization with "N-Terminal Heat Shock gp96 Protein (rNT (gp96))" Induced Strong and Sustained Th1-Type Cytokines in Immunized Mice.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 215, doi. 10.3390/vaccines9030215
- By:
- Publication type:
- Article
Revisiting the Elusive Hepatitis C Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Hepatitis C virus vaccine development: old challenges and new opportunities.
- Published in:
- National Science Review, 2015, v. 2, n. 3, p. 285, doi. 10.1093/nsr/nwv040
- By:
- Publication type:
- Article
Pseudotyping retrovirus like particles vaccine candidates with Hepatitis C virus envelope protein E2 requires the cellular expression of CD81.
- Published in:
- AMB Express, 2019, v. 9, n. 1, p. 1, doi. 10.1186/s13568-019-0741-5
- By:
- Publication type:
- Article
Toxicology and biodistribution study of CIGB-230, a DNA vaccine against hepatitis C virus.
- Published in:
- Human & Experimental Toxicology, 2009, v. 28, n. 8, p. 479, doi. 10.1177/0960327109106438
- By:
- Publication type:
- Article
Validación de la técnica de determinación de proteínas totales por el método microcoomassie a doble longitud de onda para la muestra de producto terminado del antígeno de la nucleocápsida del virus de la hepatitis C.
- Published in:
- Revista VacciMonitor (Vacunología y Temas Afines), 2013, v. 22, n. 2, p. 14
- By:
- Publication type:
- Article
Mesenchymal Stem Cells Can Both Enhance and Inhibit the Cellular Response to DNA Immunization by Genes of Nonstructural Proteins of the Hepatitis C Virus.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8121, doi. 10.3390/ijms22158121
- By:
- Publication type:
- Article
Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey.
- Published in:
- Microbiology & Immunology, 2016, v. 60, n. 1, p. 26, doi. 10.1111/1348-0421.12349
- By:
- Publication type:
- Article
Assessment of immunological response of Hepatitis B vaccination in patients of Chronic Hepatitis C (HCV).
- Published in:
- Isra Medical Journal, 2019, v. 11, n. 5, p. 390
- By:
- Publication type:
- Article
In Silico Analysis of Neutralizing Antibody Epitopes on The Hepatitis C Virus Surface Glycoproteins.
- Published in:
- Cell Journal (Yakhteh), 2023, v. 25, n. 1, p. 62, doi. 10.22074/CELLJ.2022.253363
- By:
- Publication type:
- Article
Construction and Immunogenicity Analysis of Hepatitis C Virus (HCV) Truncated Non-Structural Protein 3 (NS3) Plasmid Vaccine.
- Published in:
- Jundishapur Journal of Microbiology, 2016, v. 9, n. 3, p. 1, doi. 10.5812/jjm.33909
- By:
- Publication type:
- Article
Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0317520
- By:
- Publication type:
- Article
Hepatitis A Virus Vaccination among Injecting Drug Users: Do We Have to Change the Vaccination...
- Published in:
- Clinical Infectious Diseases, 2000, v. 31, n. 3, p. 847, doi. 10.1086/314011
- By:
- Publication type:
- Article
Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Delivery of a Hepatitis C Virus Vaccine Encoding NS3 Linked to the MHC Class II Chaperone Protein Invariant Chain Using Bacterial Ghosts.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 525, doi. 10.3390/biomedicines12030525
- By:
- Publication type:
- Article
Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 33, n. 6, p. 619, doi. 10.1111/j.1365-2036.2010.04570.x
- By:
- Publication type:
- Article
The GAVI Alliance.
- Published in:
- Journal of Global Health, 2012, v. 2, n. 2, p. 1, doi. 10.7189/jogh.02.020202
- Publication type:
- Article
Letter to the Editor Resocialization and retirement of laboratory chimpanzees.
- Published in:
- 2004
- By:
- Publication type:
- Letter
A road map to viral hepatitis elimination in BC by 2030.
- Published in:
- British Columbia Medical Journal, 2024, v. 66, n. 2, p. 58
- By:
- Publication type:
- Article
Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 2, p. 1, doi. 10.1371/journal.ppat.1006235
- By:
- Publication type:
- Article
Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 11, p. 1, doi. 10.1371/journal.ppat.1005264
- By:
- Publication type:
- Article
Production and immunogenicity of different prophylactic vaccines for hepatitis C virus (Review).
- Published in:
- Experimental & Therapeutic Medicine, 2022, v. 24, n. 1, p. N.PAG, doi. 10.3892/etm.2022.11401
- By:
- Publication type:
- Article
The innovation of the subspecialty of Paediatric Virology: An interview with Research Professor of Molecular Virology Anna Kramvis.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 4, p. 3335, doi. 10.3892/etm.2017.5008
- By:
- Publication type:
- Article
Hepatitis C Vaccines, Antibodies, and T Cells.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01480
- By:
- Publication type:
- Article
Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01194
- By:
- Publication type:
- Article
Hepatitis C Virus Reactivation Following COVID-19 Vaccination – A Case Report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0181578
- By:
- Publication type:
- Article
Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178398
- By:
- Publication type:
- Article
Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165047
- By:
- Publication type:
- Article
News.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 7, p. i, doi. 10.1093/cid/civ666
- By:
- Publication type:
- Article
Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 10, p. 1411, doi. 10.1093/cid/ciu643
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- 2013
- Publication type:
- Table of Contents
Prevention and Management of Hepatitis C Virus Infection Among People Who Inject Drugs: Moving the Agenda Forward.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. NP, doi. 10.1093/cid/cit330
- Publication type:
- Article
HEPATITIS B VACCINE SAFE.
- Published in:
- AIDS Patient Care & STDs, 2000, v. 14, n. 2, p. 104
- Publication type:
- Article
Engerix B vaccine approved.
- Published in:
- AIDS Patient Care & STDs, 1998, v. 12, n. 11, p. 874
- Publication type:
- Article
A Potential Lead from Acacia nilotica (L.) Delile Against Hepatitis C virus - An In silico Approach.
- Published in:
- Indian Journal of Pharmaceutical Sciences, 2021, v. 83, n. 3, p. 443
- By:
- Publication type:
- Article
Moving closer to a mouse model for hepatitis C.
- Published in:
- Nature Medicine, 2009, v. 15, n. 3, p. 251, doi. 10.1038/nm0309-251
- Publication type:
- Article
People to watch: Hongkui Deng.
- Published in:
- Nature Medicine, 2006, v. 12, n. 3, p. 262, doi. 10.1038/nm0306-262c
- By:
- Publication type:
- Article
Screening for hepatitis C at the time of the pandemic: Need to adjust the shot.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1918, doi. 10.1111/liv.15314
- By:
- Publication type:
- Article
Hepatitis C screening during SARS‐CoV‐2 testing or vaccination. Experience in an area of southern Italy in the province of Salerno.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1467, doi. 10.1111/liv.15273
- By:
- Publication type:
- Article
Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 4, p. 602, doi. 10.1111/liv.13550
- By:
- Publication type:
- Article
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.
- Published in:
- Liver International, 2016, v. 36, n. 7, p. 954, doi. 10.1111/liv.13049
- By:
- Publication type:
- Article
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin.
- Published in:
- Liver International, 2016, v. 36, n. 7, p. 971, doi. 10.1111/liv.13069
- By:
- Publication type:
- Article
Best strategies for global HCV eradication.
- Published in:
- Liver International, 2013, v. 33, p. 68, doi. 10.1111/liv.12063
- By:
- Publication type:
- Article
Electrically Oscillating Plasmonic Nanoparticles for Enhanced DNA Vaccination against Hepatitis C Virus.
- Published in:
- Advanced Functional Materials, 2017, v. 27, n. 5, p. n/a, doi. 10.1002/adfm.201604139
- By:
- Publication type:
- Article